Overview

Study of Gemcitabine and Abraxane for Pancreas Cancer

Status:
Terminated
Trial end date:
2016-12-01
Target enrollment:
Participant gender:
Summary
A Phase II trial of gemcitabine plus nab-paclitaxel in the second line setting
Phase:
Phase 2
Details
Lead Sponsor:
Georgetown University
Treatments:
Albumin-Bound Paclitaxel
Gemcitabine
Paclitaxel